Cardiovascular presentations during the COVID-19 pandemic: an interrupted time series analysis.

Hari Prakash Sritharan, Harrison Nguyen, Usaid Khalil Allahwala, Ravinay Bhindi
{"title":"Cardiovascular presentations during the COVID-19 pandemic: an interrupted time series analysis.","authors":"Hari Prakash Sritharan, Harrison Nguyen, Usaid Khalil Allahwala, Ravinay Bhindi","doi":"10.1093/pubmed/fdae248","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The broader implications of the Coronavirus disease 2019 pandemic on cardiovascular hospitalizations remain unclear. We aimed to assess trends in cardiovascular presentations during the Coronavirus disease 2019 pandemic.</p><p><strong>Methods: </strong>This multicentre study examined cardiovascular presentations from March 2018 to February 2023. Patients with cardiovascular presentations were identified through administrative health records using ICD-10-AM diagnosis codes. Four key study periods were analysed: T0-pre-pandemic, T1-first lockdown, T2-easing of restrictions and T3-release of restrictions and widespread vaccination. Interrupted time series analysis was used to predict weekly cardiovascular presentations, with the mean difference between actual and predicted numbers assessed for significance.</p><p><strong>Results: </strong>Overall, 116 518 patients were included across three major public hospitals in Australia. Cardiovascular presentations were significantly lower in T1 than predicted, with a mean decline of 13.1% (SD 16.2%; P = 0.004). There was a significant difference between the expected and actual number of most cardiovascular presentations in T2 and T3, apart from a significant reduction in cardiomyopathy and heart failure presentations during T3 (4.5% [SD 23.7%]; P = 0.007).</p><p><strong>Conclusions: </strong>Cardiovascular presentations were significantly lower during the initial lockdown phase of the COVID-19 pandemic; this attenuated with easing of social restrictions and widespread vaccination, except for persistent reduction in cardiomyopathy and heart failure presentations.</p>","PeriodicalId":94107,"journal":{"name":"Journal of public health (Oxford, England)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of public health (Oxford, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/pubmed/fdae248","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The broader implications of the Coronavirus disease 2019 pandemic on cardiovascular hospitalizations remain unclear. We aimed to assess trends in cardiovascular presentations during the Coronavirus disease 2019 pandemic.

Methods: This multicentre study examined cardiovascular presentations from March 2018 to February 2023. Patients with cardiovascular presentations were identified through administrative health records using ICD-10-AM diagnosis codes. Four key study periods were analysed: T0-pre-pandemic, T1-first lockdown, T2-easing of restrictions and T3-release of restrictions and widespread vaccination. Interrupted time series analysis was used to predict weekly cardiovascular presentations, with the mean difference between actual and predicted numbers assessed for significance.

Results: Overall, 116 518 patients were included across three major public hospitals in Australia. Cardiovascular presentations were significantly lower in T1 than predicted, with a mean decline of 13.1% (SD 16.2%; P = 0.004). There was a significant difference between the expected and actual number of most cardiovascular presentations in T2 and T3, apart from a significant reduction in cardiomyopathy and heart failure presentations during T3 (4.5% [SD 23.7%]; P = 0.007).

Conclusions: Cardiovascular presentations were significantly lower during the initial lockdown phase of the COVID-19 pandemic; this attenuated with easing of social restrictions and widespread vaccination, except for persistent reduction in cardiomyopathy and heart failure presentations.

COVID-19 大流行期间的心血管症状:间断时间序列分析。
背景:2019年冠状病毒病大流行对心血管住院治疗的广泛影响仍不清楚。我们旨在评估冠状病毒病 2019 年大流行期间心血管疾病的发病趋势:这项多中心研究调查了 2018 年 3 月至 2023 年 2 月期间的心血管病例。通过使用 ICD-10-AM 诊断代码的行政健康记录确定心血管疾病患者。对四个关键研究时段进行了分析:T0-大流行前、T1-首次封锁、T2-放松限制、T3-放开限制并广泛接种疫苗。采用间断时间序列分析预测每周心血管病发病情况,并评估实际发病人数与预测人数之间的平均差异是否显著:澳大利亚三家大型公立医院共纳入了 116 518 名患者。T1的心血管病发病率明显低于预测值,平均下降了13.1%(标准差为16.2%;P = 0.004)。除了心肌病和心力衰竭的发病率在 T3 期显著下降(4.5% [SD 23.7%];P = 0.007)外,大多数心血管疾病的发病率在 T2 期和 T3 期的预期和实际发病率之间存在显著差异:结论:在COVID-19大流行的最初封锁阶段,心血管病发病率明显降低;随着社会限制的放松和疫苗接种的普及,心血管病发病率有所下降,但心肌病和心力衰竭发病率持续下降。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信